Efficacy of tocilizumab in conventional treatment-refractory adult-onset still's disease: Multicenter retrospective open-label study of thirty-four patients

Arthritis and Rheumatology

Volumn 66, Issue 6, 2014, Pages 1659-1665

  Ortiz Sanjuán, Francisco ^a   Blanco, Ricardo ^a   Calvo Rio, Vanesa ^a   Narvaez, Javier ^b   Rubio Romero, Esteban ^c   Olivé, Alejandro ^d   Castañeda, Santos ^e   Gallego Flores, Adela ^f   Hernández, M Victoria ^g   Mata, Cristina ^a   Ros Vilamajo, Inmaculada ^h   Sifuentes Giraldo, Walter Alberto ⁱ   Caracuel, Miguel A ^j   Freire, Mercedes ^k   Gõmez Arango, Catalina ^l   Llobet, José ^m   Manrique Arija, Sara ⁿ   Marras, Carlos ^o   Moll Tuduri, Concepciõn ^p   Plasencia Rodriguez, Chamaida ^q   Rosellõ, Rosa ^r   Urruticoechea, Ana ^s   Velloso Feijoo, Maria L ^t   Del Blanco, Jordi ^u   González Vela, M Carmen ^a   Rueda Gotor, Javier ^a   Pina, Trinitario ^a   Loricera, Javier ^a   González Gay, Miguel A ^a   more..

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^f Hospital de Merida   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h HOSPITAL SON LLÀTZER   (Spain)

ⁱ HOSPITAL RAMÓN Y CAJAL   (Spain)

^j HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^k HOSPITAL JUAN CANALEJO   (Spain)

^l HOSPITAL DE BASURTO   (Spain)

^m Hospital Sant Pau   (Spain)

ⁿ HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^o HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^p Hospital Mateu Orfila   (Spain)

^q HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^r HOSPITAL SAN JORGE   (Spain)

^s HOSPITAL CAN MISSES   (Spain)

^t HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^u Hospital Sant Jaume de Calella   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CORTICOSTEROID; FERRITIN; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER ENZYME; METHOTREXATE; PREDNISONE; TOCILIZUMAB;

ABNORMAL LABORATORY RESULT; ADOLESCENT; ADULT; ADULT ONSET STILL DISEASE; AGED; ANEMIA; ARTHROPATHY; ARTICLE; BIOLOGICAL THERAPY; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; ENTEROCOLITIS; EPSTEIN BARR VIRUS INFECTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; FEVER; FOLLOW UP; HERPES ZOSTER; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTERVERTEBRAL DISK DEGENERATION; LEUKOCYTOSIS; LEUKOPENIA; LYMPHADENOPATHY; MAINTENANCE DRUG DOSE; MALE; NEUTROPENIA; OPEN STUDY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PYELONEPHRITIS; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN MANIFESTATION; TOOTH INFECTION; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-6; RETROSPECTIVE STUDIES; STILL'S DISEASE, ADULT-ONSET; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901594789     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38398     Document Type: Article

References (16)

1. Riera E, Olive A, Narvaez J, Holgado S, Santo P, Mateo L, et al. Adult onset Still's disease: review of 41 cases. Clin Exp Rheumatol 2011; 29: 331-6.
2. Crispin JC, Martinez-Banos D, Alcocer-Varela J,. Adult-onset Still disease as the cause of fever of unknown origin. Medicine (Baltimore) 2005; 84: 331-7.
3. Hoshino T, Ohta A, Yang D, Kawamoto M, Kikuchi M, Inoue Y, et al. Elevated serum interleukin 6, interferon-γ, and tumor necrosis factor-α levels in patients with adult Still's disease. J Rheumatol 1998; 25: 396-8.
4. Fujii T, Nojima T, Yasuoka H, Satoh S, Nakamura K, Kuwana M, et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease: association with chronic articular disease. Rheumatology (Oxford) 2001; 40: 1398-404.
5. Chen DY, Lan JL, Lin FJ, Hsieh TY,. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin- 18 in patients with active, untreated adult-onset Still's disease. Arthritis Rheum 2005; 53: 320-7.
6. Kremer JM, Blanco R, Brzosko M, Burgos-Vargas R, Halland AM, Vernon E, et al. Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year. Arthritis Rheum 2011; 63: 609-21.
7. De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012; 367: 2385-95.
8. Puechal X, deBandt M, Berthelot JM, Breban M, Dubost JJ, Fain O, et al. Tocilizumab in refractory adult Still's disease. Arthritis Care Res (Hoboken) 2011; 63: 155-9.
9. De Bandt M, Saint-Marcoux B,. Tocilizumab for multirefractory adult-onset Still's disease. Ann Rheum Dis 2009; 68: 153-4.
10. Perdan-Pirkmajer K, Praprotnik S, Tomsic M,. A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature. Clin Rheumatol 2010; 29: 1465-7.
11. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19: 424-30.
12. Schoels MM, van der Heijde D, Breedveld FC, Burmester GR, Dougados M, Emery P, et al. Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement. Ann Rheum Dis 2013; 72: 583-9.
13. Rueda Gotor J, Blanco Alonso R,. Tocilizumab in rheumatoid arthritis. Reumatol Clin 2011; 6 (Suppl 3): 29-32.
14. Elkayam O, Jiries N, Dranitzki Z, Kivity S, Lidar M, Levy O, et al. Tocilizumab in adult Still's disease: the Israeli experience. [abstract] Arthritis Rheum 2012; 64 Suppl: S83.
15. De Boysson H, Fevrier J, Nicolle A, Auzary C, Geffray L,. Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence. Clin Rheumatol 2013; 32: 141-7.
16. Van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL,. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996; 39: 34-40.